The 13th World Congress of Regenerative Medicine & Stem Cell (RMSC-2019)

Preliminary Program

Chapter times on those days will not be finalized until the overall program schedule is completed.

Program Tracks
(Please click each Assembly for detailed program information)

Assembly 1 Leadership Summit of Regenerative Medicine & Stem Cells
-Rethinking Global Strategy, Law, Ethic, Tech Trend, Financing and Market Outlook

Assembly 2 Forum of Breaking Basic Researches on RMSC
-From Wisdom, Knowledge, Theory to Understanding and Decoding the Secrete Triad World of RMSC & Tissue Engineering

Assembly 3 Disruptive and Innovative Hi-Tech Summit
-Hottest RMSC Technologies and Innovations Generating Great Impacts on the Next Decade

Assembly 4 Smart Triad Bioprocessing Symposium
-Robust, High Yield, and High-Quality Production Processes of Stem Cells, Tissues and Regenerative Biotherapy

Assembly 5 Career & Business Development Forum
-Talents, Networking, Business, Investment, and Contribute to the Society

Assembly 6 Translational Regenerative Medicine and Stem Cell Engineering Forum
-Vigorously Developing the Regenerative Potentials and Applications for Healthy, Wealthy, Beautiful and Solemn Life

Assembly 7 Sino-X/Cross-Trait RMSC Partnership Forum
-Accelerating RMSC Scientific Research of Bilateral, Multilateral International or Regional Collaborations

Assembly 8 Case Studies on Current Trend of Chinese Stem Cell R&D
-Sharing Successful Experiences on Legal, Policy and Best Practices of Chinese Stem Cell R & D and Innovative Treatment

Assembly 9 Posters, Exposition and Matchmaking
-Sourcing Novel Products, New Methods and Technology, Instrument and Equipment, Innovative Treatment and Potential Project Partnership

Assembly 10 Social & Cultural Events
-Enjoying the Happy Time, Delicious Food, Unforgettable Friendship, Exotic Romance, Chinese Culture and Happy Tour

Assembly 6 Translational Regenerative Medicine and Stem Cell Engineering Forum

Chapter 26 Top 10 Cases in Human Stem Cell Medicine
Time: 08:30-10:30, November 3, 2019 (Sunday);Place: Dalian International Conference Center, China
Chair	*Dr. Sohel Talib,* Director, Therapeutics, California Institute for Regenerative Medicine, USA
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Under Preparation Dr. Antonio Lee, Global Head, Business Development, MEDIPOST Co., Ltd., Korea
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Title: Under Preparation Dr. Sohel Talib, Director, Therapeutics, California Institute for Regenerative Medicine, USA
09:50-10:15	Speech Opportunity Available Abstract and Biography:Submit Here
10:15-10:30	Coffee Break
Chapter 27 Update on Current Human Tissue Engineering
Time:13:30-15:30, November 1, 2019 (Friday); Place: Dalian International Conference Center, China
Chair	*Call for chair*
Co-Chair	*Call for Co-chair*
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available Abstract and Biography:Submit Here
14:00-14:25	Speech Opportunity Available Abstract and Biography:Submit Here
14:25-14:50	Speech Opportunity Available Abstract and Biography:Submit Here
14:50-15:15	Title: Long Term Follow up Results Post-Burn Scar Deformations Using Adcl/Autologus Fat Injections Dr. Ashok Kumar Gupta, Bombay Hospital Institute of Medical Sciences, India
15:15-15:30	Coffee Break
Chapter 28 Top Trend of Regenerative Medicine
Time:13:30-17:10, November 1, 2019 (Friday); Place:Dalian International Conference Center, China
Chair	*Dr. Rene J Alvarez,* Professor, Jefferson University Hospitals, USA
Co-Chair	*Dr. Nick Zhang,* Chairman and CEO, QIAGEN (Suzhou) Translational Medicine Co. Ltd., China
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Microbes, Man and Medicine Dr. Henry C. Lin, Chief, New Mexico VA Health Care System, Mexico
14:00-14:25	Speech Opportunity Available Abstract and Biography:Submit Here
14:25-14:50	Title: Under Preparation Dr. Rene J Alvarez, Professor, Jefferson University Hospitals, USA
14:50-15:15	Title: Under Preparation Dr. Wanhong Xing, Deputy Chief Physician, The Second Hospital of Shanxi Medical University, China
15:15-15:30	Coffee Break
15:30-15:55	Title: Under Preparation Dr. Nick Zhang, Chairman and CEO, QIAGEN (Suzhou) Translational Medicine Co. Ltd., China
15:55-16:20	Title: Under Preparation Dr. Joel I Osorio, Founder, Regener Age Clinic, Mexico
14:50-15:15	Title: Under Preparation Dr. Hazem Barmada, Serious Stem Cell Research Doctor, Mississippi Stem cell Treatment Center, USA
14:50-15:15	Title: Under Preparation Dr. Lubna Noor, Consultant Breast Surgeon, The City & Hospital, USA
Session 29-1: Stem Cell Therapy on Heart Disorders
Time:08:30-12:10, November 2, 2019 (Saturday); Place:Dalian International Conference Center, China
Chair	*Dr. Robert Roberts,* Chair, International Society of Cardiovascular Translational Research, USA
Co-Chair	*Dr. Bella Koifman,* Director, Tel Aviv Sourasky Medical Center, Israel
08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Under Preparation Dr. Jinpei Ye, Professor and Chair of Stem Cell, Shanxi University, China
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Title: Under Preparation Dr. Robert Roberts, Chair, International Society of Cardiovascular Translational Research, USA
09:50-10:15	Title: "End-stage" Constrictive Pericarditis Dr. Ramachandran Muthiah, Thoothukudi Medical College Hospital, India
10:15-10:30	Coffee Break
10:30-10:55	Title: Under Preparation Dr. Bella Koifman, Director, Tel Aviv Sourasky Medical Center, Israel
10:55-11:20	Title: Vaccination of Hep B in Healthy Adults: Reponse Rates and Epidemiology Dr. Jacques Choucair, Specialist, Saint Joseph University, France
11:20-11:45	Title: Cardiovascular Progenitors Generated from Laminin-Based Differentiation System Improves Cardiac Function after Myocardial Infarction Dr. Lynn Yap Yan Wen, Senior Research Fellow, Duke-NUS Graduate Medical School, Singapore
11:45-12:10	Title: Big Heart Syndrome-Common Problem in Peadatric Heart Transplantation, Causes and Conributoru Factors Dr. R. Ravi Kumar, Senior Cardiologist, Gleneagles Global Hospital, India
Session 29-2: Stem-Cell Therapy of Diabetes
Time:13:30-17:10, November 2, 2019 (Saturday); Place:Dalian International Conference Center, China
Chair	*Dr. Edward B. Jude,* Honorary Professor, University of Manchester, UK
Co-Chair	Dr. Shridhar J Pandya, Managing Director, GPLIFE HEALTHCARE PVT LTD, India
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Stem Cells and NF-kappa B Signaling in Antidiabetic Effects and in Restoration of Functions of Tissue Bisamide Derivative of Dicarboxylic Acid (BDDA) in Metabolic Disorders Dr. Evgenii G. Skurikhin, Head, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Russia
14:00-14:25	Title: Under Preparation Dr. Robert Roberts, Chair, International Society of Cardiovascular Translational Research, USA
14:25-14:50	Title: Diabetes/Metabolism Research and Reviews the Patient-Perceived Difficulty in Diabetes Treatment (PDDT) Scale Identifies Barriers to Care Dr. Orly Tamir, Director, The Gertner Institute for Epidemiology and Health Policy Research, Israel
14:50-15:15	Title: Mechanisms of Weight Loss upon Sodium Oxybate Treatment in Narcolepsy Type 1 Dr. Mink Schinkelshoek, PhD Candidate, Leiden University Medical Centre, Netherlands
15:15-15:30	Coffee Break
15:30-15:55	Speech Opportunity Available Abstract and Biography:Submit Here
15:55-16:20	Title: A New Hope for Diabetes: -Gplife Advanced Diabetic Support Tablet as an Adjuvant Therapy in Patients with Diabetes Dr. Shridhar J Pandya, Managing Director, GPLIFE HEALTHCARE PVT LTD, India
16:20-16:45	Speech Opportunity Available Abstract and Biography:Submit Here
16:45-17:10	Title: Development of Beta-Cell Replacement Therapy for Diabetes Dr. Shimon Efrat, Professor, Tel Aviv University, Israel
Session 29-4: RMSC for Brain and CNS Diseases
Time:13:30-17:10, November 2, 2019 (Saturday); Place:Dalian International Conference Center, China
Chair	*Dr. Andrew McEvoy,* Reader, UCL Queen Square Institute of Neurology, UK
Co-Chair	*Dr. J.-M. Burgunder,* Professor, University of Bern, Germany
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Gene Correction, induced Pluripotent Stem Cells Disease Modelling and Stem Cell Therapy for Inherited Retinal Dystrophies Dr. Slaven Erceg, Group Leader, Stem Cell Therapies in Neurodegenerative Diseases, Spain
14:00-14:25	Speech Opportunity Available Abstract and Biography:Submit Here
14:25-14:50	Title: Under Preparation Dr. Andrew McEvoy, Reader, UCL Queen Square Institute of Neurology, UK
14:50-15:15	Title: Role of Systemic Immunocytes in Exacerbating Brain Inflammatory Pathology in Models of Alzheimer’S Disease Dr. Renato Bernardini, Full Professor, University of Catania Medical School, Italy
15:15-15:30	Coffee Break
15:30-15:55	Title: Gene and Cell Therapy in Huntington’s Disease: Neuroregeneration Dr. J.-M. Burgunder, Professor, University of Bern, Germany
15:55-16:20	Title: Under Preparation Dr. Mas Ahmed, Consultant, Queen's University Hospital, UK
16:20-16:45	Title: p75ECD-Fc: Biological Dsease-modifying Terapy for Alzheimer's Dsease Dr. Ehud Hauben, Senior Medical Scientist, Basil Hetzel Institute, Australia
16:45-17:10	Title: The Road to Clinic: Safety and Efficacy of Human Embryonic Stem Cells Derived Astrocytes Following Intrathecal Transplantation in Sod1g93a and Nsg Animal Models Dr. Michal Izrael, VP of R&D ALS and Nurodegenerative Dseases, Kadimastem Ltd., Israel
Session 29-6: Cancer Stem Cell Therapy
Time:08:30-12:10, November 3, 2019 (Sunday); Place:Dalian International Conference Center, China
Chair	*Dr. Cheng-Wen Wu,* Academician, Academia Sinica, Taiwan
Co-Chair	Dr. Ningsun Yang, Fellow, American Association for the Advancement of Science, USA
08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Antibody Drug Conjugates as a Precision Drug Delivery Tool to Treat Cancers with Tumor Stem Cells Dr. Andrew C. Huang, Chief Scientific Officer, MabPlex International,Ltd., China
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Title: Gene and Stem Cell Therapy for Lung Injury: in Vivo Reprogramming of Alveolar Epithelial Cells Dr. Cheng-Wen Wu, Academician, Academia Sinica, Taiwan
09:50-10:15	Title: How the Internet has Changed Survival for the Deadliest of Human Cancers Dr. Paul M Zeltzer, Neurosurgeon, UCLA Medical Center, USA
10:15-10:30	Coffee Break
10:30-10:55	Title: Under Preparation Dr. Ningsun Yang, Fellow, American Association for the Advancement of Science, USA
10:55-11:20	Title: Under Preparation Dr. Arkesh Mehta, Chief Executive Officer, OncoBindi Therapeutics, USA
11:20-11:45	Title: Low Dose Continuous Treatment with Capecitabine in Patients with Breast Cancer Dr. John Carpenter, Oncologist, University of Alabama at Birmingham, USA
11:45-12:10	Title: Evaluation of Long Noncoding RNA MALAT1 in Lung Carcinoma Dr. Dingding Zhang, Professor, University of Electronic Science and Technology of China and Sichuan Provincial People Hospital, China
Session 29-10: Stem Cell Therapy for Bloodand Genetic Diseases
Time:08:30-10:30, November 3, 2019 (Sunday); Place:Dalian International Conference Center, China
Chair	*Dr. Jan Jacques Michiels,* Professor, ICAR International Collaborations and Academic Research, The Netherlands
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available Abstract and Biography:Submit Here
09:00-09:25	Title: Translation of the PVSG/WHO Classifications into the Clinical, Laboratory, Molecular and Pathological (2019 CLMP) Criteria for Distinct Myeloproliferative Neoplasms Caused by JAK2V617F JAK2EXON12, CALR, MPL515 and TPO Driver Mutations Dr. Jan Jacques Michiels, Professor, ICAR International Collaborations and Academic Research, The Netherlands
09:25-09:50	Speech Opportunity Available Abstract and Biography:Submit Here
09:50-10:15	Title: The Grim Side of Stem Cell Therapy: Indonesian Experience Dr. Jeanne A. Pawitan, Professor, University of Indonesia, Indonesia
10:15-10:30	Coffee Break
Chapter 30 Endless World of Stem Cells
Time:13:30-17:10, November 1, 2019 (Friday);Place:Dalian International Conference Center, China
Chair	*Dr. Yang D. Teng,* President, The American Society for Neural Therapy and Repair, USA
Co-Chair	*Dr. Willie Lin,* CEO, Meridigen Biotech Co., Ltd., Taiwan
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Isolation and Culture of Stem Leydig Cells from Adult Rat Testis Dr. Haolin Chen, Professor, Wenzhou Medical University, China
14:00-14:25	Title: Extracellular Vesicles Derived from MiR-27b-Overexpressing Bone Marrow Mesenchymal Stem Cells Attenuate Apoptosis and Inflammation of OA in A Rat Model Dr. Hui Qi, Beijing Jishuitan Hospital, China
14:25-14:50	Title: Under Preparation Dr. Yang D. Teng, President, The American Society for Neural Therapy and Repair, USA
14:50-15:15	Title: The Transitions of Neural Stem Cell Property and Formation of The Gyrencephalic Brain Dr. Fumio Matsuzaki, RIKEN Center for Developmental Biology, Japan
15:15-15:30	Coffee Break
15:30-15:55	Title: Modulation of Parietal Cytokine and Chemokine Gene Profiles by Mesenchymal Stem Cell as a Basis for Neurotrauma Recovery Dr. Willie Lin, CEO, Meridigen Biotech Co., Ltd., Taiwan
15:55-16:20	Title: Osmotic Behaviour of Human Mesenchymal Stem Cells: Experiments and Modeling for Cryo-preservation Optimization Dr. Alberto Cincotti, Associate Professor, University of Cagliarim, Italy
16:20-16:45	Title: Mesenchymal Stem Cells- friend or Enemy in the Fight against Breast Cancer Dr. Alaa Al-Shareeda, King Abdullah International Medical Research Center, Saudi Arabia
16:45-17:10	Title: Formation of Heterodimers at P2Y Receptors and the Use of Extracellular ATP as A Support in the Treatment of Leukemia in Leukemia Stem Cells Dr. Antonio Carlos Ribeiro Filho, Mogi Das Cruzes University, Brazil
Session 30-7: Cancer Stem Cells
Time:13:30-17:10, November 2, 2019 (Saturday);Place:Dalian International Conference Center, China
Chair	*Dr. Marco Falasca,* Professor, The Blizard Institute, UK
Co-Chair	*Call for Co-chair*
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available Abstract and Biography:Submit Here
14:00-14:25	Title: Pancreatic Cancer Tumorspheres are Cancer Stem-Like Cells with Increased Chemoresistance and Reduced Metabolic Potential Dr. Marco Falasca, Professor, The Blizard Institute, UK
14:25-14:50	Speech Opportunity Available Abstract and Biography:Submit Here
14:50-15:15	Title: Celastrol Derivatives Strongly Inhibit Proliferation, Migration and Cancer Stem Cell Properties in Ovarian Cancer Cells Dr. Xiaojing Li, Lecturer, Liaocheng University, China
15:15-15:30	Coffee Break
10:30-10:55	Speech Opportunity Available Abstract and Biography:Submit Here
10:55-11:20	Title: Under Preparation Dr. A. C. Matin, Professor of Microbiology & Immunology, Stanford University School of Medicine, USA
11:20-11:45	Speech Opportunity Available Abstract and Biography:Submit Here
11:45-12:10	Title: From Cieculating Tumor Cells to Fetal Nucleated Red Blood Cells Dr. Xing-Zhong Zhao, Cheung Kong Professor of Physics, Wuhan University, China
Chapter 31 A Stem Cell’s Fate
Time:08:30-10:30, November 2, 2019 (Saturday);Place:Dalian International Conference Center, China
Chair	*Dr. David T. Harris,* Director, University of Arizona, USA
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available Abstract and Biography:Submit Here
09:00-09:25	Title: Long Term Banking of Stem Cells and Tissues for Clinical Use Dr. David T. Harris, Director, University of Arizona, USA
09:25-09:50	Speech Opportunity Available Abstract and Biography:Submit Here
09:50-10:15	Speech Opportunity Available Abstract and Biography:Submit Here
10:15-10:30	Coffee Break
Chapter 32 Top Hospital Clinical Research Capacity Briefing
Time:08:30-10:30, November 2, 2019 (Saturday);Place:Dalian International Conference Center, China
Chair	*Call for Chair*
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available Abstract and Biography:Submit Here
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Speech Opportunity Available Abstract and Biography:Submit Here
09:50-10:15	Speech Opportunity Available Abstract and Biography:Submit Here
10:15-10:30	Coffee Break
Chapter 33 Community Voice of Stem Cells and Regenerative Medicine
Time:08:30-10:30, November 2, 2019 (Saturday);Place:Dalian International Conference Center, China
Chair	*Dr. Sergei Snopov,*Deputy Dean, National Research University Higher School of Economics, Russia
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available Abstract and Biography:Submit Here
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Title: Zajdela Hepatoma Clonal Cell Lines as A Novel Model for in Vitro Studies of Cancer Stem Cells Dr. Sergei Snopov, Deputy Dean, National Research University Higher School of Economics, Russia
09:50-10:15	Speech Opportunity Available Abstract and Biography:Submit Here
10:15-10:30	Coffee Break
Chapter 34 Anti-aging RMSC-Are RMSC Panaceas or Forever Young Possible
Time:08:30-10:30, November 2, 2019 (Saturday);Place:Dalian International Conference Center, China
Chair	*Dr. Juergen Lademann,* President, International Federation of Societies of Cosmetic Chemists, Germany
Co-Chair	*Dr. Coen Gho,*CSO, Hair Science Institute, Netherlands
08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Aging is a Problem in Physics not Biology Dr. Leonard Hayflick, Professor of Anatomy, University of California, USA
09:00-09:25	Title: Healthy Life Protects against Skin Aging: iIn Vivo Analysis of the Interaction of Antioxidants and Free Radicals in Human Skin Dr. Juergen Lademann, President, International Federation of Societies of Cosmetic Chemists, Germany
09:25-09:50	Speech Opportunity Available Abstract and Biography:Submit Here
09:50-10:15	Title: Follicular Stem Cells in Cosmetic & Regenerative Medicine Dr. Coen Gho, CSO, Hair Science Institute, Netherlands
10:15-10:30	Coffee Break
Chapter 35 Plant and Animal Stem Cells-Next Big Things in Stem Cell Cosmetic Industry
Time:08:30-10:30, November 2, 2019 (Saturday); Place:Dalian International Conference Center, China
Chair	*Call for Chair*
Co-Chair	*Dr. Frederic Berger,* Senior Group Leader, Gregor Mendel Institute of Molecular Plant Biology GmbH, Austria
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available Abstract and Biography:Submit Here
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Title: Under Preparation Dr. Frederic Berger, Senior Group Leader, Gregor Mendel Institute of Molecular Plant Biology GmbH, Austria
09:50-10:15	Speech Opportunity Available Abstract and Biography:Submit Here
10:15-10:30	Coffee Break
Chapter 36 Stem Cells Ethic Debate-What should be right Universal Moral Conducts
Time:13:30-17:10, November 1, 2019 (Friday); Place:Dalian International Conference Center, China
Chair	*Dr. Amish Patel,*Senior Director, Emergent Biosolutions, USA
Co-Chair	*Dr. Toshi-Hiko Kobayashi,* Professor, The University of Tokyo, Japan
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Where are You on the Health-Spectrum? FMTVDM, Absolute AI Quantification of Heart Disease and Cancer Used to Provide Patient-Specific Treatment; Saving Time, Money and Lives Dr. Richard M Fleming, Professor, The Camelot Foundation, USA
14:00-14:25	Speech Opportunity Available Abstract and Biography:Submit Here
14:25-14:50	Title: Under Preparation Dr. Amish Patel, Senior Director, Emergent Biosolutions, USA
14:50-15:15	Title: The Reletionship Between the Locations and Oraginates of Multiple Retroperitoneal Tumors in CT Dr. Feng Yuan-chun, Professor, Peking University International Hospital, China
15:15-15:30	Coffee Break
15:30-15:55	Title: Invaluable Combination of Regulatory Sciences and Research & Development of Japan all over the World Dr. Toshi-Hiko Kobayashi, Professor, The University of Tokyo, Japan
15:55-16:20	Title: Regulatory Framework Conditions for Stem Cell Therapies in Europe and Germany Dr. Mathias Klümper, Lawyer, Mitglied der Alliance of European Life Sciences Law Firms, Germany
16:20-16:45	Title: New Opportunities and New Challenges for Regenerative Medicine in the U.S: Policy Developments and Recent Enforcement from the Food and Drug Administration (FDA) Dr. Torrey Cope, Partner, Sidley Austin LLP, USA
16:45-17:10	Title: Qualification of Impurities in Drug Substances and Drug Products Dr. Raphael Nudelman, Director, Teva Pharmaceutical Industries, Israel
Chapter 37 Challenges and Solutions to RMSC
Time:08:30-10:30, November 2, 2019 (Saturday); Place:Dalian International Conference Center, China
Chair	*Dr. Lidia Cappellina,* Head of R&D Outsourcing Management, Chiesi Farmaceutici S.P.A., Italy
Co-Chair	*Call for Co-chair*
08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Under Preparation Dr. Lidia Cappellina, Head of R&D Outsourcing Management, Chiesi Farmaceutici S.P.A., Italy
09:00-09:25	Speech Opportunity Available Abstract and Biography:Submit Here
09:25-09:50	Speech Opportunity Available Abstract and Biography:Submit Here
09:50-10:15	Title: Effectiveness of Plant Biophenols against the Cellular and Animal Models of Alzheimer's Disease Dr. Syed H. Omar, Charles Sturt University, Australia
10:15-10:30	Coffee Break

	Abstract Format
	Sponsorship Application
	Exhibition Application